POC or Point-of-care testing, also known as bedside testing is a diagnostic testing at or close to the point or position of care at the same place and time of patient care. Diagnostic tests have been restricted to the diagnostic centre or medical laboratory, thereby sending off blood samples away from patient care site entailed a waiting period ranging from a few days to a few weeks for the results to arrive. This necessitated continuous care of the patient by the same treatment, devoid of the crucial information and led to the deployment of point of care testing. This in turn led to growth of the cardiac POC testing devices market. POC tests are simple diagnostic tests that may be carried out at the bedside.
Cardiac POC testing is a diagnostic test related to the heart that is carried out close to the point of care of the patient. Principally, they are simple blood tests that include coagulation testing and cholesterol testing, among others. Coagulation testing helps doctors assess risk of extreme bleeding or developing thrombosis inside blood vessels in the body, including the heart. Cardiac point-of-care tests include brain natriuretic peptide analysis and Troponin, which are mainly employed to identify cardiovascular ailments such as coronary syndromes, heart failure, and myocardial infarction. Cardiac POC testing device help to detect enzymes that are released at some point in heart failure and in vital cardiac circumstances such as synthesizing troponin, kinase, brain natriuretic peptides and lactate dehydrogenase isoenzymes. Moreover, these tests help doctors detect and distinguish between angina and myocardial infarction, which are two of the major causes of heartache and death related to the same. Cardiac POC significantly decreases the time taken to get the reports. In most cases, the reports are supplied within an hour post submission of the test sample. Thus, cardiac POC tests help reduce turnaround time considerably, thereby allowing for instant patient response and effectual management of cardiac diseases. These functionalities will drive growth of the market in cardiac POC testing devices during the forecast period (2016–2024).
Cardiac POC Testing Devices Market Taxonomy
On the basis of product type, the market is classified into:
On the basis of end users, the market is classified into:
Cardiac diseases and the conditions leading to them, including hypercholesterolemia, require constant monitoring of the patient and accordingly adjusting the dosage and the combination of drugs prescribed. High cholesterol can also be hereditary in nature. According to the FH Foundation—a global charity focused on increasing awareness regarding Familial Hypercholesterolemia—1 in 200-500 people suffered from familial hypercholesterolemia worldwide in 2015. With increasing population, the number is likely to rise in the future, thereby leading to an increase in demand for testing cholesterol levels in individuals. This in turn would propel overall growth of the cardiac POC testing devices market.
Growing prevalence of cardiac diseases, especially in Asia Pacific to drive growth of cardiac POC testing devices market
According to a report published by the Heart Foundation—an Australia-based organization focused on increasing awareness about heart disease—heart disease (including Stroke and other Cardiovascular Diseases) is the main cause of death in the U.S., leading to the death of nearly 787,000 people in 2011. The same report stated that around 720,000 individuals in the U.S. suffer from heart attacks each year. Of these attacks, 515,000 are first heart attacks and the rest 205,000 happened in patients who have already experienced a heart attack. North America is characterized by a robust healthcare infrastructure and is well equipped with technologically advanced instruments such as new age cardiac POC testing devices for monitoring the condition in patients suffering from cardiovascular diseases. These are some of the reasons for dominance of the North America in the global cardiac POC testing devices industry.
However, Asia Pacific is likely to gain significant momentum in the near future. According to a report published by National Centre for Biotechnology Information in 2013, cardiovascular disease (CVD) is the major cause of death in the globe and around half of these CVD cases were expected to be reported in Asia. When compared with the Western world, most Asian countries, excluding Japan, Singapore, Thailand, and South Korea, account for high mortality (age-adjusted) from CVD, thereby augmenting growth of the market.
Some of the major companies operating in the cardiac POC testing devices market in the current scenario are Abbott Laboratories, Alere Inc., BG Medicine Inc., Roche Diagnostics, Beckman Coulter, Inc., Medtronic Inc., and Boston Scientific Corp.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.[email protected]
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.